Lyngsø Julie, Ramlau-Hansen Cecilia Høst, Bay Bjørn, Ingerslev Hans Jakob, Hulman Adam, Kesmodel Ulrik Schiøler
Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus.
The Fertility Clinic, Regional Horsens Hospital, Horsens.
Clin Epidemiol. 2017 Dec 15;9:699-719. doi: 10.2147/CLEP.S146496. eCollection 2017.
The aim was to investigate whether coffee or caffeine consumption is associated with reproductive endpoints among women with natural fertility (ie, time to pregnancy [TTP] and spontaneous abortion [SAB]) and among women in fertility treatment (ie, clinical pregnancy rate or live birth rate).
This study was a systematic review and dose-response meta-analysis including data from case-control and cohort studies.
An extensive literature search was conducted in MEDLINE and Embase, with no time and language restrictions. Also, reference lists were searched manually. Two independent reviewers assessed the manuscript quality using the Newcastle-Ottawa Scale (NOS). A two-stage dose-response meta-analysis was applied to assess a potential association between coffee/caffeine consumption and the outcomes: TTP, SAB, clinical pregnancy, and live birth. Heterogeneity between studies was assessed using Cochrane -test and statistics. Publication bias was assessed using Egger's regression test.
The pooled results showed that coffee/caffeine consumption is associated with a significantly increased risk of SAB for 300 mg caffeine/day (relative risk [RR]: 1.37, 95% confidence interval [95% CI]: 1.19; 1.57) and for 600 mg caffeine/day (RR: 2.32, 95% CI: 1.62; 3.31). No association was found between coffee/caffeine consumption and outcomes of fertility treatment (based on two studies). No clear association was found between exposure to coffee/caffeine and natural fertility as measured by fecundability odds ratio (based on three studies) or waiting TTP (based on two studies).
Results from this meta-analysis support the growing evidence of an association between coffee/caffeine intake and the risk of SAB. However, viewing the reproductive capacity in a broader perspective, there seems to be little, if any, association between coffee/caffeine consumption and fecundity. In general, results from this study are supportive of a precautionary principle advised by health organizations such as European Food Safety Authority (EFSA) and World Health Organization (WHO), although the advised limit of a maximum of two to three cups of coffee/200-300 mg caffeine per day may be too high.
旨在研究对于自然受孕的女性(即受孕时间[TTP]和自然流产[SAB])以及接受生育治疗的女性(即临床妊娠率或活产率)而言,饮用咖啡或摄入咖啡因是否与生殖结局相关。
本研究为一项系统评价和剂量反应荟萃分析,纳入了病例对照研究和队列研究的数据。
在MEDLINE和Embase数据库中进行了全面的文献检索,无时间和语言限制。此外,还手动检索了参考文献列表。两名独立评审员使用纽卡斯尔-渥太华量表(NOS)评估手稿质量。采用两阶段剂量反应荟萃分析来评估咖啡/咖啡因摄入量与以下结局之间的潜在关联:TTP、SAB、临床妊娠和活产。使用Cochrane检验和统计量评估研究之间的异质性。使用Egger回归检验评估发表偏倚。
汇总结果显示,对于每天摄入300毫克咖啡因(相对风险[RR]:1.37,95%置信区间[95%CI]:1.19;1.57)和每天摄入600毫克咖啡因(RR:2.32,95%CI:1.62;3.31),咖啡/咖啡因摄入与SAB风险显著增加相关。未发现咖啡/咖啡因摄入与生育治疗结局之间存在关联(基于两项研究)。在以受孕几率比衡量的自然生育能力方面(基于三项研究)或等待TTP方面(基于两项研究),未发现咖啡/咖啡因暴露与自然生育能力之间存在明确关联。
该荟萃分析的结果支持了越来越多的证据表明咖啡/咖啡因摄入与SAB风险之间存在关联。然而,从更广泛的角度看待生殖能力,咖啡/咖啡因摄入与生育力之间似乎几乎没有关联(如果有也是微乎其微)。总体而言,本研究结果支持欧洲食品安全局(EFSA)和世界卫生组织(WHO)等卫生组织建议的预防原则,尽管建议的每天最多饮用两到三杯咖啡/200 - 300毫克咖啡因的限量可能过高。